Abstracts (HTML) List of Authors

Bachmann, M.

Twenty-Year Trends in Time-to-Diagnosis of Paediatric Ischaemic Stroke in Switzerland

Bader, I.

Genotypes and Phenotypes of a Novel Neurodevelopmental Disorder Caused by Biallelic Mutations in BUB1

Balint, B.

Palliative GPi-DBS for Severe Dystonia in SCN2A-Related Developmental and Epileptic Encephalopathy
Atypical Pantothenate Kinase-Associated Neurodegeneration: Intrafamilial Heterogeneity and Response to GPi Deep Brain Stimulation

Barash, S.

Safety Outcomes from a Phase 3, Randomised, Double-Blind, Placebo-Controlled Study of Fremanezumab for the Preventive Treatment of Episodic Migraine in Children and Adolescents
Efficacy Outcomes from a Phase 3, Randomised, Double-Blind, Placebo-Controlled Study of Fremanezumab for the Preventive Treatment of Episodic Migraine in Children and Adolescents

Bartosch, J.

Characterization of MOG-Specific B Cells in Pediatric MOGAD

Bassetti, C. L.

From Theory to Action: Raising Awareness for Brain Health Through the #BrainHealthChallenge2025

Bauder, F.

Twenty-Year Trends in Time-to-Diagnosis of Paediatric Ischaemic Stroke in Switzerland

Bechtiger, V.

Automatic Video Segmentation-Based 3D Reconstruction for Comprehensive Median Nerve Assessment in Healthy, T1D, and SMA Pediatric Populations

Becker, L.-L.

TRPM3-Associated Disorders: Clinical Spectrum and Treatment Options

Beichler, C.

Genotypes and Phenotypes of a Novel Neurodevelopmental Disorder Caused by Biallelic Mutations in BUB1

Beilschmidt, L.

The Societal Costs of Duchenne Muscular Dystrophy in Germany

Bektas, K.

Automatic Video Segmentation-Based 3D Reconstruction for Comprehensive Median Nerve Assessment in Healthy, T1D, and SMA Pediatric Populations

Benke, T.

Trofinetide for the Treatment of Rett Syndrome: Long-Term Safety and Efficacy Results from the Open-Label LILAC and LILAC-2 Studies
Efficacy and Safety of Trofinetide for the Treatment of Rett Syndrome: Results from the Pivotal Phase 3 LAVENDER Study

Benzing, V.

Efficacy and Feasibility of the Mio-Training: A Metacognitive Intervention to Strengthen Cognitive Development of Children and Adolescents. An Evaluation Study

Bernbeck, B.

A Rare Complication on the Spot: Tumor-Associated Hemorrhages in Pediatric LGG

Berry-Kravis, E.

Trofinetide for the Treatment of Rett Syndrome: Long-Term Safety and Efficacy Results from the Open-Label LILAC and LILAC-2 Studies
Efficacy and Safety of Trofinetide for the Treatment of Rett Syndrome: Results from the Pivotal Phase 3 LAVENDER Study

Berweck, S.

A Novel Concept for Multimodal Intensive Rehabilitation for Children with Hemiparesis: Magic Moves

Bettica, P.

Long-Term Safety of Givinostat in Patients with Duchenne Muscular Dystrophy: Results from an Open-Label Extension Study

Bevot, A.

UBR5-Associated Neurodevelopmental Disorder with Global Developmental Delay and Multi-Organ Involvement: A Case Report

Bigi, S.

Patient and Parent Perception of the Diagnostic Process in Swiss Children with Pediatric-Onset Inflammatory Brain Diseases

Bill, M.

The Societal Costs of Duchenne Muscular Dystrophy in Germany

Bishop, K.

Trofinetide for the Treatment of Rett Syndrome: Long-Term Safety and Efficacy Results from the Open-Label LILAC and LILAC-2 Studies
Efficacy and Safety of Trofinetide for the Treatment of Rett Syndrome: Results from the Pivotal Phase 3 LAVENDER Study

Biskup, S.

TRPM3-Associated Disorders: Clinical Spectrum and Treatment Options

Bittigau, P.

Safety Outcomes from a Phase 3, Randomised, Double-Blind, Placebo-Controlled Study of Fremanezumab for the Preventive Treatment of Episodic Migraine in Children and Adolescents
Efficacy Outcomes from a Phase 3, Randomised, Double-Blind, Placebo-Controlled Study of Fremanezumab for the Preventive Treatment of Episodic Migraine in Children and Adolescents
Administrative Epidemiology and Treatment Patterns of Paediatric Migraine: Results from a Retrospective Claims Data Analysis

Bley, A.

Leukencephalopathy with Calcifications and Cysts: A Case Report of Clinical Improvement with Tiapride

Bonfert, M.

Exploring Neuromuscular Mechanisms of Repetitive Neuromuscular Magnetic Stimulation: A Randomized, Sham-Controlled Study in Healthy Controls
From Setbacks to Outlooks: Cognitive-Linguistic Outcomes Following Pediatric TBI: A Scoping Review
Cognitive Communication Disorders and Its Academic Consequences in Adolescents After TBI: A Single-Case Comparison

Bonfert, M. V.

A Novel Concept for Multimodal Intensive Rehabilitation for Children with Hemiparesis: Magic Moves
What Goals and Needs do Adolescents and Young Adults Identify for Rehabilitation After Traumatic Brain Injury? A Quantitative Online Survey
How Postural Patterns Change After a Concussion: A Spectral Analysis Approach to Postural Control in Pediatric Patients Throughout Their Recovery from Mild Traumatic Brain Injury

Borggräfe, I.

Identification of a Rare New Cause of (Cerebral Venous Sinus) Thrombosis and Thrombocytopenia

Börner-Schröder, C.

Exploring Neuromuscular Mechanisms of Repetitive Neuromuscular Magnetic Stimulation: A Randomized, Sham-Controlled Study in Healthy Controls

Brandsema, J.

Long-Term Safety of Givinostat in Patients with Duchenne Muscular Dystrophy: Results from an Open-Label Extension Study

Brechbühl, D.

Twenty-Year Trends in Time-to-Diagnosis of Paediatric Ischaemic Stroke in Switzerland

Breitkreutz, J.

Preclinical and First-in-Human Evidence Supporting 4-Hydroxybenzoic Acid as a Treatment for COQ2-associated Mitochondrial Disease

Breu, M.

Fluctuating Hyperkinesia and Epileptic Seizures in a Child: Syndrome Spectrum or Two Entities?: An Unsolved Case of an Encephalopathy

Bria, A.

From Theory to Action: Raising Awareness for Brain Health Through the #BrainHealthChallenge2025

Brigitte, B.

A Rare Complication on the Spot: Tumor-Associated Hemorrhages in Pediatric LGG

Broser, P.

Genotype-Based Prediction of Functional Disease Progression in Duchenne Muscular Dystrophy Using AI-Supported Analysis

Broser, P. J.

Automatic Video Segmentation-Based 3D Reconstruction for Comprehensive Median Nerve Assessment in Healthy, T1D, and SMA Pediatric Populations

Brugger, M.

Biallelic Variants in TRAPPC11 Cause a Neurodevelopmental Disorder with Achalasia and Alacrima

Brunet, T.

Biallelic Variants in TRAPPC11 Cause a Neurodevelopmental Disorder with Achalasia and Alacrima

Brunner-Krainz, M.

Two Patients with AGS9: Divergent Clinical Courses of a Rare Metabolic Disease

Bryson, J.

Safety Outcomes from a Phase 3, Randomised, Double-Blind, Placebo-Controlled Study of Fremanezumab for the Preventive Treatment of Episodic Migraine in Children and Adolescents
Efficacy Outcomes from a Phase 3, Randomised, Double-Blind, Placebo-Controlled Study of Fremanezumab for the Preventive Treatment of Episodic Migraine in Children and Adolescents

Buccella, F.

Effectiveness of Ataluren in Patients with nmDMD: Confirmatory Evidence from the STRIDE Registry

Buros, S. Cornaz

Tethered Cord in CTNNB1 Neurodevelopmental Disorder, a Not-so-Rare Comorbidity: Results of a Parent Survey and a Clinical Example

Büttner-Kunert, J.

What Goals and Needs do Adolescents and Young Adults Identify for Rehabilitation After Traumatic Brain Injury? A Quantitative Online Survey
From Setbacks to Outlooks: Cognitive-Linguistic Outcomes Following Pediatric TBI: A Scoping Review
Cognitive Communication Disorders and Its Academic Consequences in Adolescents After TBI: A Single-Case Comparison